glutathione disulfide has been researched along with Dyskeratosis Congenita, X-Linked in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aykin-Burns, N; Buckingham, EM; Goldman, FD; Klingelhutz, AJ; Spitz, DR; Westin, ER | 1 |
1 other study(ies) available for glutathione disulfide and Dyskeratosis Congenita, X-Linked
Article | Year |
---|---|
The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency.
Topics: Blotting, Western; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Dyskeratosis Congenita; Glutathione; Glutathione Disulfide; Humans; Oxidative Stress; Polymerase Chain Reaction; Signal Transduction; Telomerase; Tumor Suppressor Protein p53 | 2011 |